About Klinikum Augsburg; Frauenklinik
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
3
University Hospital Tuebingen
2
Clinical Trials at Klinikum Augsburg; Frauenklinik
During the past decade, Klinikum Augsburg; Frauenklinik conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 2 clinical trials were completed, i.e. on
average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Safety and Tolerability Study of Assisted and Self-Administered Subcutaneous (SC) Herceptin (Trastuzumab) as Adjuvant Therapy in Early Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer
2012-05-17
2020-02-19
Completed
2,577
Therapy Management With Nab-Paclitaxel in Daily Routine
2015-12-01
2021-12-01
Unknown status
1,200
Pertuzumab in First Line Treatment of HER2-positive Metastatic Breast Cancer Patients
2016-03-01
2020-07-01
Unknown status
300
A Study to Evaluate the Pharmacokinetics, Efficacy, and Safety of Subcutaneous Administration of the Fixed-Dose Combination of Pertuzumab and Trastuzumab in Combination With Chemotherapy in Participants With HER2-Positive Early Breast Cancer
2018-06-14
2023-11-16
Active, not recruiting
500
A Study Evaluating the Efficacy and Safety of Adjuvant Atezolizumab or Placebo and Trastuzumab Emtansine for Participants With HER2-Positive Breast Cancer at High Risk of Recurrence Following Preoperative Therapy
2021-05-04
2034-10-26
Recruiting
1,700
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Klinikum Augsburg; Frauenklinik
According to Clinical.Site data, the most researched conditions in "Klinikum Augsburg; Frauenklinik" are
"Metastatic Breast Cancer" (2 trials), "Breast Cancer" (1 trials), "Breast Neoplasms" (1 trials) and "Early Breast Cancer" (1 trials). Many other conditions were trialed in "Klinikum Augsburg; Frauenklinik" in a lesser frequency.
Clinical Trials Intervention Types at Klinikum Augsburg; Frauenklinik
Most popular intervention types in "Klinikum Augsburg; Frauenklinik" are "Drug" (3 trials), "Procedure" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.
The name of intervention was led by "Atezolizumab" (1 trials), "Cyclophosphamide" (1 trials), "Docetaxel" (1 trials), "Doxorubicin" (1 trials) and "FDC of Pertuzumab and Trastuzumab SC" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Klinikum Augsburg; Frauenklinik
The vast majority of trials in "Klinikum Augsburg; Frauenklinik" are
4 trials for "All" genders and 1 trials for "Female" genders.
Clinical Trials Status at Klinikum Augsburg; Frauenklinik
Currently, there are NaN active trials in "Klinikum Augsburg; Frauenklinik".
undefined are not yet recruiting,
1 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in Klinikum Augsburg; Frauenklinik,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Klinikum Augsburg; Frauenklinik, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 3 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".